CMS Administrator Dr. Mehmet Oz said that Medicaid’s rapid spending growth is unsustainable and criticized state financing ...
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.
Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...
As Employers Face Spike in Healthcare Costs, How Can They Optimize Digital Health in Benefit Design?
With healthcare costs for companies projected to jump 9% in 2026, the largest increase in more than a decade, ROI for digital health solutions is critical. In a recent webinar, executives from Solera ...
From left to right: Moderator Michael Kalishman, chief venture officer, Sentara Health; Nick Culbertson, managing director, Techstars; Dr. Ngoc-Anh Nguyen, vice chair of research, Houston Methodist ...
WellTheory, a digital health company for autoimmune disease, announced on Tuesday that it has raised $14 million in Series A funding, which will help the company scale and advance its AI. Atherton, ...
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...
When Baltimore Dental College opened in 1837 as the world’s first dental school, students spent three years in training. More than 180 years later — despite enormous advances in treatments, case ...
Bristol Myers Squibb is securing an opportunity to compete in the next generation of cell therapies through the $1.5 billion acquisition of Orbital Therapeutics, a startup with a lead program nearing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback